Assaypro 60284-05141 | Human F
actor IX (Factor 9) Monoclonal AssayLite Antibody (FITC Conjugate)- 询价
- Assaypro
- 60284-05141
- 2026年08月21日
- IF, FACS
- Mouse
相关产品推荐更多 >
Assaypro 11343-05011 | Mouse Fibronectin (FN) Antibody
询价Assaypro 32267-05111 | Human Heat Shock Factor 2-Binding Protein (HSF2BP) Antibody
询价Assaypro 32117-05171 | Human ELAV-like Protein 2 (ELAVL2) AssayLite Antibody (PerCP Conjugate)
询价Assaypro 32831-05171 | Human Cyclin D2 AssayLite Antibody (PerCP Conjugate)
询价Assaypro 35143-05141 | Mouse Aldose Reductase (AR) AssayLite Antibody (FITC Conjugate)
询价
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
细胞污染识别与处理全攻略：5 种常见类型+关键误区Cytoscape 教程来了！快速实现顶刊同款通路网络图五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 免疫原：
Human factor IX expressed in CHO cells
- 保存条件：
见COA
- 库存：
请咨询
- 供应商：
维百奥生物
- 宿主：
Mouse
- 应用范围：
IF, FACS
维百奥生物授权代理Assaypro全系列产品
❏ 产品信息
品名：Human Factor IX (Factor 9) Monoclonal AssayLite Antibody (FITC Conjugate)
货号：60284-05141
规格：2 x 50 ug
❏ 产品描述
Tag：Factor 9, Coagulation Factor 9, Coagulation Factor IX, Factor IX, Christmas Disease Factor
Species：Human
Format：IgG-FITC Conjugate
Associated Disease：Blood Disorder
UniProt：P00740
Purity：Affinity Purified
Presentation：Lyophilized from PBS pH 7.4, 20 mg/ml BSA, 0.02% Sodium Azide, and 4% Trehalose
Host：Mouse
Storage：2-8°C, Do Not Freeze
Application：IF, FACS
Immunogen：Human factor IX expressed in CHO cells
本产品仅用于科研，更多产品信息请联系我们的销售人员。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Purification, Quantification, and Functional Analysis of Complement Factor H
a monoclonal anti-FH antibody as ligand. Other affinity chromatography ligands, including cardiolipin and trinitrophenyl-bovine serum albumin (TNP-BSA), can be used to purify human FH and also FH from a wide range of vertebrates, including mammals, birds, bony
Chimerization of a Monoclonal Antibody for Treating Hodgkin's Lymphoma
Ber-H2 which recognizes the human CD30 molecule with high specificity and affinity (2 ). CD30, a member of the nerve growth factor (NGF) tumor necrosis factor receptor (TNFR) superfamily (3 ), is strongly expressed on the pathognomonic Hodgkin (H
【翻译】Development trends for monoclonal antibody cancer therapeutics
). However, since 2000, humanized and human mAbs have been entering clinical study at approximately the same rate (4.3 versus 4.5 mAbs per year, respectively). Figure 1 | Categories of monoclonal antibody cancer therapeutics entering clinical study during 1980–1989
技术资料暂无技术资料 索取技术资料
